Abstract
Microdeletions in the AZF region of the Y chromosome are among the most frequent genetic causes of male infertility, although the specific role of the genes located in this region is not fully understood. AZFa and AZFb deletions impair spermatogenesis since no spermatozoa are found in the testis. Deletions of the AZFc region, despite being the most frequent in azoospermic patients, do not correlate with spermatogenic failure. Therefore, the aim of this work was to develop a screening method to ascertain the presence of the main spermatogenesis candidate genes located in the AZFc region in the light of the identification of those responsible for spermatogenic failure. DAZ, CDY, BPY2, PRY, GOLGA2LY and CSGP4LY genes were selected on the basis of their location in the AZFc region, testis-only expression, and confirmed or predicted protein codification. AMEL and SRY were used as amplification controls. The identification of Real Time PCR products was performed by High Resolution Melting analysis with SYTO 9 as intercalating dye. The herein described method allows a rapid, simple, low-cost, high-throughput screening for deletions of the main AZFc genes in patients with spermatogenic failure. This provides a strategy that would accelerate the identification of spermatogenesis candidate genes in larger populations of patients with non-obstructive idiopathic azoospermia.
Highlights
Infertility affects about 15% of the couples trying to conceive
The following genes were selected on the basis of their location in the AZFc region of the Y chromosome, testis-only expression and confirmed or predicted protein codification: deleted in azoospermia (DAZ), chromodomain protein Y (CDY), basic protein Y 2 (BPY2), PTPBL-related gene on Y (PRY), GOLGA2LY and CSGP4LY
The characterization of spermatogenesis candidate genes may lead to improvements in the diagnosis and treatment of male patients suffering from infertility
Summary
Infertility affects about 15% of the couples trying to conceive. In half of the cases, the underlying cause can be partially or totally attributed to the male partner, and 10–15% of the cases could be due to genetic abnormalities [1]. The azoospermia factor region (AZF) and its sub-regions AZFa, AZFb and AZFc are the main targets for molecular diagnosis [3,4] These AZF loci are routinely screened for possible microdeletions using sequence tagged sites (STSs), as recommended by the European Academy of Andrology (EAA) [5]. The use of gene-specific primers flanking specific locations enables to obtain information on the potential mechanisms, and the extension of the deletions. These studies highlighted the improved value of including genespecific markers in the minimal set of markers for the analysis [8]
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have